CLINICAL_TRIALS
trial_result
· 2012-06-13
Clinical Trial Update: Effects of ONO-2506PO in Patients With Alzheimer's Disease [Phase 2]
Summary
A Phase 2 clinical trial evaluating ONO-2506PO in patients with Alzheimer's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ono Pharma USA Inc | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED